Micro-Biopsy Forceps in the Assessment of Peritoneal Carcinomatosis: A Possible New Indication?
- Author:
Cecilia BINDA
1
;
Emanuele DABIZZI
;
Emanuele SINAGRA
;
Adele FORNELLI
;
Luca SARAGONI
;
Vincenzo CENNAMO
;
Andrea ANDERLONI
;
Carlo FABBRI
Author Information
- Publication Type:Case Report
- From:Clinical Endoscopy 2021;54(4):613-617
- CountryRepublic of Korea
- Language:English
- Abstract: Peritoneal carcinomatosis (PC) is defined as a metastatic involvement of the peritoneum by several other primary sites and it is characterized by a marked worsening of prognosis, with limited treatment opportunities. Subsequently, PC should be ruled out before any invasive treatment is administered. A new through-the-needle micro-biopsy forceps (MF) was recently introduced that permits micro-histology cores. In this case series, we evaluated the feasibility of MF in the assessment of PC to complete patient diagnostic work-ups. Five consecutive patients referred for endoscopic ultrasound staging were sampled using MF. Sampling was feasible in all patients with a technical success of 100%. No adverse events were reported in any cases. This technique was feasible and safe with a technical success rate of 100%. It permitted sampling of peritoneal irregularity, obtained high-quality tissue fragments in all cases, and enabled an additional assessment, i.e., immunohistochemical staining.
